A new study funded by Eli Lilly found that mixing compounded tirzepatide with vitamin B12 can lead to impurities that may pose a patient safety risk. A compounding pharmacy industry group says the ...

Pharmaceutical giant Eli Lilly is warning patients about the potential danger of taking compounded tirzepatide, marketed as Zebound and Mounjaro, mixed with vitamin B12. After testing copycat drug ...

April 23 (UPI) --Eli Lilly Wednesday filed lawsuits against four telehealth companies alleging they are deceiving consumers by selling compounds of slightly-different versions of Lilly drugs. Lilly is ...

Renée Fabian is Lead Editor for Pet Health at Forbes Advisor. She has over 10 years experience as a journalist and editor covering pet and human health topics. Renée previously worked as senior pet ...

Eli Lilly & Co. warned that the active ingredient in its weight-loss blockbuster Zepbound could pose a risk to patients when mixed with vitamin B12, a combination sold by US drug compounders. Lilly ...